Leaflet ROBINUL 0.2mg / ml solution for injection

Indicated for: chronic obstructive pulmonary disease

Route of administration: injectable

Substance: glycopyrronium bromide (bronchodilator)

ATC: A03AB02 (Alimentary tract and metabolism | Drugs for functional gastrointestinal disorders | Synthetic anticholinergics, quaternary ammonium compounds)

Precautions:
Glaucoma warning
Glaucoma warning

Use caution if you have glaucoma or increased eye pressure.

Anticholinergic effects
Anticholinergic effects

May cause dry mouth, constipation, urinary retention, or blurred vision.

Elderly warning
Elderly warning

Older people may have an increased risk of side effects.

Glycopyrronium bromide is an anticholinergic medication primarily used for the treatment of obstructive respiratory diseases, such as chronic obstructive pulmonary disease (COPD). It works by blocking muscarinic receptors in the airways, leading to relaxation of bronchial smooth muscles and airway dilation, making breathing easier.

It is indicated for:

- Maintenance treatment of COPD to relieve symptoms such as shortness of breath.
- Reducing the frequency of disease exacerbations.

Glycopyrronium bromide is administered via an inhaler, usually once daily, as directed by a doctor.

Side effects may include dry mouth, throat irritation, cough, constipation, headache, or, rarely, allergic reactions. It is contraindicated in patients with hypersensitivity to glycopyrronium or other anticholinergics and should be used with caution in those with narrow-angle glaucoma, urinary retention, or other conditions that may be worsened by anticholinergic effects.

General data about ROBINUL 0.2mg / ml

  • Substance: glycopyrronium bromide
  • Date of latest medicines list: 01-01-2026
  • Product code: W69323001
  • Concentration: 0.2mg / ml
  • Pharmaceutical form: solution for injection
  • Quantity: 10
  • Product type: Generic medicine
  • Prescription status: P-RF - Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.

Marketing authorisation

  • Manufacturer: KERN PHARMA, S.L. - SPANIA
  • Holder: CN UNIFARM S.A. - ROMANIA
  • Number: 768/2022/01
  • Shelf life: 3 years

Pharmaceutical forms available for glycopyrronium bromide

Concentrations available for glycopyrronium bromide

  • 0.2mg/ml
  • 2.2mg/dose
  • 320mcg/ml
  • 44mcg